Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
Clinical trial NCT00001270 · COMPLETED
Trial details
- NCT number
- NCT00001270
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1991-06-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.